Description
+ Include: 74 videos + 1 pdf, size: 16.7 GB
+ Target Audience: cardiologist
+ Sample video: contact me for sample video
+ Information:
HFSA Virtual AHFTC Board Certification Review 2022
Comprehensive Virtual Review in Advanced Heart Failure & Transplant Cardiology
Join this focused and flexible virtual review experience, originally held August 12–14, 2022. Designed around the ABIM AHFTC exam blueprint, this program includes pre-recorded fundamentals, interactive live sessions, and post-course support—ideal for exam prep and clinical mastery.
What You’ll Gain
-
A structured Fundamentals webinar series covering heart failure epidemiology, pathophysiology, diagnostics, and comorbidities
-
Three full days of virtual sessions, including concise expert presentations, live polling, Q&A panels, and case-based discussions
-
Bonus access to post-meeting faculty office hours, offering follow-up guidance and clarification
-
Downloadable slide decks, access to an exam-focused question bank, and a curated reading list to enhance your learning experience
Who Should Enroll
-
Cardiologists and heart failure specialists preparing for the ABIM Advanced Heart Failure & Transplant Cardiology certification exam
-
Internal medicine physicians, fellows, and trainees seeking a high-yield, board-aligned review
-
Advanced Practice Providers, nurses, and allied professionals working in heart failure, transplant, or mechanical circulatory support teams
-
Academic clinicians and educators involved in heart failure and transplant cardiology training programs
Why This Program Stands Out
-
Fully aligned with the ABIM AHFTC exam blueprint for focused, relevant preparation
-
Combines on-demand fundamentals with interactive live sessions and real-world clinical insights
-
Features live polling, case reviews, and Q&A panels to reinforce learning and clinical reasoning
-
Includes practical tools like a downloadable question bank, slide sets, and a topic-based reading guide
Strengthen Your Command of Advanced Heart Failure
Whether you’re preparing for board certification or advancing your day-to-day practice, the HFSA Virtual AHFTC Board Certification Review 2022 delivers a flexible, comprehensive solution for building expertise and confidence in heart failure and transplant cardiology.
▶️ Start your on-demand access now and accelerate your clinical growth.
+ Topics:
HFSA22_BCR_AdvanceProg_8.11.pdf
Adult Congenital Heart Disease for the HF Specialist.mp4
Advanced Heart Failure Defining the Phenotype and Patient Selection for Advanced Therapies.mp4
Application and Implementation of Drug Therapies for Heart Failure with Reduced Ejection Fraction.mp4
Assessment of Functional Capacity including cardiopulmonary exercise testing.mp4
Cardio Renal Failure Interactions in Heart Failure.mp4
Cardio-Oncology for the HF boards.mp4
Cardiogenic Shock Management.mp4
Clinico-Pathologic Correlates in Heart Failure Images for the Heart Failure Boards.mp4
Device Therapy in Heart Failure I – Sudden Death Prevention.mp4
Device Therapy in Heart Failure II – CRT.mp4
Diabetes and COPD.mp4
Diagnosis and Clinical Assessment.mp4
Healthcare Disparities in HF.mp4
Heart Failure Epidemiology and Risk Factors.mp4
Heart Transplant, Clinical Outcomes and Complications.mp4
Hemodynamics in HF I.mp4
Hemodynamics in HF II.mp4
HFpEF Epidemiology, Risk Factors, Diagnosis, Management (for the boards).mp4
Immunology The Basics, PRA, Sensitization, Crossmatch.mp4
Issues in Chronic HF Disease Management (Biomarkers, Remote Monitoring, Lifestyle Interventions).mp4
LIVE Q&A – Advanced Heart Failure Defining the Phenotype and Patient Selection for Advanced Therapies.mp4
LIVE Q&A – Hemodynamics in HF II.mp4
LIVE Q&A – HFpEF Epidemiology, Risk Factors, Diagnosis, Management (for the boards).mp4
LIVE Q&A – Immunology The Basics, PRA, Sensitization, Crossmatch and Rejection Cellular and Antibody Mediated.mp4
LIVE Q&A – Managing Immunosuppression and Drugs and Heart Transplant, Clinical Outcomes and Complications.mp4
LIVE Q&A – Optimal Medical Therapy for Heart Failure with Reduced Ejection Fraction, Application and Implementation.mp4
LIVE Q&A 1.mp4
LIVE Q&A 10.mp4
LIVE Q&A 2.mp4
LIVE Q&A 3.mp4
LIVE Q&A 4.mp4
LIVE Q&A 5.mp4
LIVE Q&A 6.mp4
LIVE Q&A 7.mp4
LIVE Q&A 8.mp4
LIVE Q&A 9.mp4
Management of Common Arrhythmias I – Atrial Fib and Flutter.mp4
Management of Common Arrhythmias II.mp4
Management of Comorbidities in Heart Failure – Iron Deficiency Anemia.mp4
Management of Comorbidities in Heart Failure – Sleep Disorder.mp4
Management of Left Sided Valvular Heart Disease in Heart Failure (including functional MR, low gradient AS).mp4
Management of the Hospitalized HF Patient.mp4
Managing Immunosuppression and Drugs.mp4
MCS I Durable MCS Devices and Outcomes.mp4
MCS II Temporary Support Devices and ECMO for the Boards.mp4
MCS III MCS Complications and Patient Management.mp4
MCS IV Interactive Shock and Device Management – Case 1.mp4
MCS IV Interactive Shock and Device Management – Case 2.mp4
MCS IV Interactive Shock and Device Management – Case 3.mp4
Optimal Medical Therapy for Heart Failure with Reduced Ejection Fraction.mp4
Pathophysiology I Cellular and Energetic Considerations.mp4
Pathophysiology II Hemodynamic, Structural, and Neurohormonal Considerations.mp4
Pulmonary Hypertension – Classification and Initial Evaluation.mp4
Pulmonary Hypertension – Therapy.mp4
Q&A Faculty Panel – Day 1.mp4
Q&A Faculty Panel – Day 2.mp4
Q&A Faculty Panel – Day 3.mp4
Rejection Cellular and Antibody Mediated.mp4
RV Failure and TR Management.mp4
SESSION I Cardiac Transplantation – Part I.mp4
SESSION I Cardiac Transplantation – Part II.mp4
SESSION II Key Issues in HF Management – Part I.mp4
SESSION II Key Issues in HF Management – Part II.mp4
SESSION II Key Issues in HF Management – Part III.mp4
SESSION III Specific Heart Failure Syndromes.mp4
SESSION IV – Shock MCS.mp4
SESSION V Special Topics in HF.mp4
Specific Etiologies of HF I Common Etiologies (CAD, ETOH, Peripartum, Myocarditis).mp4
Specific Etiologies of HF II Inherited HF syndromes (including HCM, ARVC, and LVNC).mp4
Specific Etiologies of HF III Infiltrative Disorders and Restrictive Cardiomyopathy (Amyloidosis, Sarcoidosis, Hemochromatosis, Fabry).mp4
Statistics for the HF Board.mp4
Welcome & HFSA Introduction Day 1.mp4
Welcome Day 2.mp4
Welcome Day 3.mp4
Reviews
There are no reviews yet.